Cytokine Levels in Conversion Disorder

This study has been completed.
Sponsor:
Information provided by:
Trakya University
ClinicalTrials.gov Identifier:
NCT00971360
First received: September 2, 2009
Last updated: October 19, 2010
Last verified: September 2009
  Purpose

The aim of this study is whether the proinflammatory cytokine levels in patients with conversion disorder is increased or not changed in the acute phase and subacute - chronic periode, compared with controls.


Condition Intervention
Conversion Disorder
Other: conversion disorder

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Proinflammatory Cytokine Levels in Patients With Conversion Disorder

Resource links provided by NLM:


Further study details as provided by Trakya University:

Estimated Enrollment: 30
Study Start Date: September 2009
Study Completion Date: September 2010
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Conversion disorder Other: conversion disorder
Proinflammatory cytokine levels in conversion disorder
Healthy control Other: conversion disorder
Proinflammatory cytokine levels in conversion disorder

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

primary care clinic

Criteria

Inclusion Criteria:

  • Clinical diagnosis of Alzheimer's Disease

Exclusion Criteria:

  • Autoimmune disease
  • Neurological disease
  • Any organic disorder that could possibly affect proinflammatory cytokines
  • Pregnancy
  • Any drug usage within 2 weeks
  • Any active or passive immunization within 6 months
  • Any other DSM-IV axis I psychiatric disorder
  • Mental retardation
  • Developmental disorder of childhood
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00971360

Locations
Turkey
Trakya University Faculty of Medicine; Department of Psychiatry
Edirne, Turkey, 22030
Sponsors and Collaborators
Trakya University
  More Information

Publications:
Responsible Party: Trakya University Scientific Research Unit (TUBAB)
ClinicalTrials.gov Identifier: NCT00971360     History of Changes
Other Study ID Numbers: TUTFEK 2009/173
Study First Received: September 2, 2009
Last Updated: October 19, 2010
Health Authority: United States: Institutional Review Board
Turkey: Ethics Committee

Keywords provided by Trakya University:
conversion
cytokine
inflammation

Additional relevant MeSH terms:
Conversion Disorder
Hysteria
Dissociative Disorders
Somatoform Disorders
Mental Disorders
Histrionic Personality Disorder
Personality Disorders

ClinicalTrials.gov processed this record on April 16, 2014